ArticleNeuroradiology2026
Diagnostic accuracy of [
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PSMA-Targeted Theranostics in Glioblastoma Multiforme: Current Evidence and Future Perspectives.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveThis study aimed to evaluate the diagnostic accuracy of [
methodsIn this cross-sectional study, 31 lesions with suspected glioblastoma recurrence underwent [
resultsAmong the 30 patients with 31 lesions (70% male, mean age 46 years), initial MRI identified recurrence in 38.71% (n = 12), no recurrence in 35.48% (n = 11), and was indeterminate in 25.81% (n = 8) of lesions. Follow-up MRI and other clinical data confirmed recurrence in 58.06% (n = 18) and no recurrence in 41.94% (n = 13). Quantitative SPECT/CT analysis revealed a mean TBR of 13.08 ± 12.09. Visual PSMA assessment demonstrated a sensitivity of 83% and specificity of 92% when considering moderate/high uptake as positive. TBR quantitative analysis showed excellent discrimination (AUC = 0.87), with an optimal threshold of 7.55 yielding 89% sensitivity and 91% specificity. Initial MRI had 100% sensitivity and 91.67% specificity when excluding indeterminate cases. For the 8 patients with indeterminate initial MRI, both visual and quantitative PSMA parameters showed 100% accuracy in predicting the final diagnosis.
conclusion[
Indexed as
Identifiers
42207247What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.